Study on the risk signal mining related to brigatinib based on the US FDA Adverse Event Reporting System

Fu Zhonghua, Guo Zihan, Wang Mengmeng, Du Qiong, Zhai Qing

PDF(404 KB)
PDF(404 KB)
Adverse Drug Reactions Journal ›› 2023, Vol. 25 ›› Issue (1) : 34-39. DOI: 10.3760/cma.j.cn114015-20220822-00771

Study on the risk signal mining related to brigatinib based on the US FDA Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 25(1): 34-39 https://doi.org/10.3760/cma.j.cn114015-20220822-00771

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(404 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉